|

Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy

RECRUITINGSponsored by Hospital Universitari Vall d'Hebron Research Institute
Actively Recruiting
SponsorHospital Universitari Vall d'Hebron Research Institute
Started2025-01-01
Est. completion2027-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07713537

Summary

Acute ischaemic strokes occur despite the use of direct oral anticoagulants (DOACs). Evidence-based scale is necessary to assess ischemic stroke risk in atrial fibrillation (AF) patients.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patient over 18 years of age
* History of AD
* Currently on DOACs.
* Capacity to understand the study procedures and provide informed consent.

Exclusion Criteria:

* Patient with valvular AF (mitral stenosis) or mechanical valve prostheses.
* Unable to complete a follow-up period of at least 3 months from enrollment.

Conditions3

Atrial Fibrillation (AF)Heart DiseaseIschemic Stroke

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.